Personal information

Biography

My area of research revolves around nanotechnology and cancer stem cell biology and I have been working on the development of a chemotherapeutic regimen through the investigation of the mechanism of action of a novel hybrid nanoparticle in combination with the photothermal therapy.

Activities

Education and qualifications (4)

Cornell University: Ithaca, US

2024-06-01 to 2024-10-01 | Postdoctoral Research Fellow (Department of Molecular Biology and Genetics)
Education
Source: Self-asserted source
Dr. Somya Ranjan Dash

KIIT School of Biotechnology: Bhubaneswar, Orissa, IN

2018-09-10 to 2024-05-21 | PhD in Cancer Biology (School of Biotechnology)
Education
Source: Self-asserted source
Dr. Somya Ranjan Dash

Utkal University: Bhubaneswar, Orissa, IN

2016-08-06 to 2018-08-05 | M.Sc Biotechnology (P.G. Department of Biotechnology)
Education
Source: Self-asserted source
Dr. Somya Ranjan Dash

Utkal University: Bhubaneswar, Orissa, IN

2013-08-01 to 2016-09-06 | B.Sc Biotechnology (Biotechnology)
Education
Source: Self-asserted source
Dr. Somya Ranjan Dash

Professional activities (2)

Indian Science Congress Association: Kolkata, West Bengal, IN

Membership
Source: Self-asserted source
Dr. Somya Ranjan Dash

Indian Association for Cancer Research: Mumbai, IN

Membership
Source: Self-asserted source
Dr. Somya Ranjan Dash

Funding (1)

Improvement of oral cancer stem cells sensitivity using Quinacrine-gold hybrid nanoparticles and NIR exposure.

Award
Department of Science and Technology (New Delhi, IN)
Source: Self-asserted source
Dr. Somya Ranjan Dash

Works (23)

Combination of Resveratrol and PARP inhibitor Olaparib efficiently deregulates homologous recombination repair pathway in breast cancer cells through inhibition of TIP60-mediated chromatin relaxation

Medical Oncology
2024 | Journal article
EID:

2-s2.0-85181512959

Part of ISSN: 1559131X 13570560
Contributors: Sinha, S.; Paul, S.; Acharya, S.S.; Das, C.; Dash, S.R.; Bhal, S.; Pradhan, R.; Das, B.; Kundu, C.N.
Source: Self-asserted source
Dr. Somya Ranjan Dash via Scopus - Elsevier
grade
Preferred source (of 2)‎

Determining the effect of long non-coding RNA maternally expressed gene 3 (lncRNA MEG3) on the transcriptome profile in cervical cancer cell lines

Genomics
2024 | Journal article
EID:

2-s2.0-85208588334

Part of ISSN: 10898646 08887543
Contributors: Arega, S.; Dey, S.; Pani, S.; Dash, S.R.; Budhwar, R.; Kundu, C.N.; Ganguly, N.
Source: Self-asserted source
Dr. Somya Ranjan Dash via Scopus - Elsevier

Nano formulated Resveratrol inhibits PD-L1 in oral cancer cells by deregulating the association between tumor associated macrophages and cancer associated fibroblasts through IL-6/JAK2/STAT3 signaling axis

Journal of Nutritional Biochemistry
2024 | Journal article
EID:

2-s2.0-85182655165

Part of ISSN: 18734847 09552863
Contributors: Pradhan, R.; Paul, S.; Acharya, S.S.; Sinha, S.; Dash, S.R.; Kundu, C.N.
Source: Self-asserted source
Dr. Somya Ranjan Dash via Scopus - Elsevier

Near infrared-responsive quinacrine–gold hybrid nanoparticles deregulate HSP-70/P300-mediated H3K14 acetylation in ER/PR+ breast cancer stem cells

Nanomedicine
2024 | Journal article
EID:

2-s2.0-85187541571

Part of ISSN: 17486963 17435889
Contributors: Dash, S.R.; Das, C.; Das, B.; Jena, A.B.; Paul, S.; Sinha, S.; Tripathy, J.; Kundu, C.N.
Source: Self-asserted source
Dr. Somya Ranjan Dash via Scopus - Elsevier
grade
Preferred source (of 2)‎

The role of viruses in cancer progression versus cancer treatment: A dual paradigm

Life Sciences
2024 | Journal article
EID:

2-s2.0-85185375751

Part of ISSN: 18790631 00243205
Contributors: Dash, S.R.; Kundu, A.; Kundu, C.N.
Source: Self-asserted source
Dr. Somya Ranjan Dash via Scopus - Elsevier

Advances in nanomedicine for the treatment of infectious diseases caused by viruses

Biomaterials Science
2023 | Journal article
Part of ISSN: 2047-4830
Part of ISSN: 2047-4849
Contributors: Somya Ranjan Dash; Chanakya Nath Kundu
Source: Self-asserted source
Dr. Somya Ranjan Dash
grade
Preferred source (of 3)‎

Quinacrine inhibits HIF-1α/VEGF-A mediated angiogenesis by disrupting the interaction between cMET and ABCG2 in patient-derived breast cancer stem cells

Phytomedicine
2023 | Journal article
EID:

2-s2.0-85161973937

Part of ISSN: 1618095X 09447113
Contributors: Das, B.; Dash, S.R.; Patel, H.; Sinha, S.; Bhal, S.; Paul, S.; Das, C.; Pradhan, R.; Ahmed, I.; Goutam, K. et al.
Source: Self-asserted source
Dr. Somya Ranjan Dash via Scopus - Elsevier

Talazoparib enhances the quinacrine-mediated apoptosis in patient-derived oral mucosa CSCs by inhibiting BER pathway through the modulation of GCN5 and P300

Medical Oncology
2023 | Journal article
EID:

2-s2.0-85176113351

Part of ISSN: 1559131X 13570560
Contributors: Das, C.; Dash, S.R.; Sinha, S.; Paul, S.; Das, B.; Bhal, S.; Sethy, C.; Kundu, C.N.
Source: Self-asserted source
Dr. Somya Ranjan Dash via Scopus - Elsevier

Talazoparib enhances the Quinacrine-mediated apoptosis in patient-derived oral mucosa CSCs by inhibiting BER pathway through the modulation of GCN5 and P300

Research Square
2023 | Other
EID:

2-s2.0-85176403156

Contributors: Das, C.; Dash, S.R.; Sinha, S.; Paul, S.; Das, B.; Bhal, S.; Sethy, C.; Kundu, C.N.
Source: Self-asserted source
Dr. Somya Ranjan Dash via Scopus - Elsevier

Veliparib (ABT-888), a PARP inhibitor potentiates the cytotoxic activity of 5-fluorouracil by inhibiting MMR pathway through deregulation of MSH6 in colorectal cancer stem cells

Expert Opinion on Therapeutic Targets
2023 | Journal article
EID:

2-s2.0-85173975085

Part of ISSN: 17447631 14728222
Contributors: Paul, S.; Chatterjee, S.; Sinha, S.; Dash, S.R.; Pradhan, R.; Das, B.; Goutam, K.; Kundu, C.N.
Source: Self-asserted source
Dr. Somya Ranjan Dash via Scopus - Elsevier

Quinacrine inhibits cMET-mediated metastasis and angiogenesis in breast cancer stem cells

Journal of Cell Communication and Signaling
2023-05-10 | Journal article
Part of ISSN: 1873-9601
Part of ISSN: 1873-961X
Contributors: Biswajit Das; Chinmayee Sethy; Subhajit Chatterjee; Somya Ranjan Dash; Saptarshi Sinha; Subarno Paul; Kunal Goutam; Chanakya Kundu
Source: Self-asserted source
Dr. Somya Ranjan Dash
grade
Preferred source (of 2)‎

Near-infrared enhances antiangiogenic potentiality of quinacrine-gold hybrid nanoparticles in breast cancer stem cells via deregulation of HSP-70/TGF-β

Nanomedicine
2023-03-14 | Journal article | Author
Part of ISSN: 1743-5889
Part of ISSN: 1748-6963
Contributors: Dr. Somya Ranjan Dash; BISWAJIT DAS; Chinmay Das; Saptarshi Sinha; Subarno Paul; Rajalaxmi Pradhan; Chanakya Kundu
Source: Self-asserted source
Dr. Somya Ranjan Dash
grade
Preferred source (of 3)‎

Cancer-induced pain management by nanotechnology-based approach

Current Pharmaceutical Biotechnology
2023-01-23 | Journal article
Part of ISSN: 1389-2010
Contributors: Somya Ranjan Dash; Chanakya Nath Kundu
Source: Self-asserted source
Dr. Somya Ranjan Dash
grade
Preferred source (of 2)‎

Quinacrine inhibits cMET-mediated metastasis and angiogenesis in breast cancer stem cells

Research Square
2022 | Other
EID:

2-s2.0-85167258859

Contributors: Das, B.; Sethy, C.; Chatterjee, S.; Dash, S.R.; Sinha, S.; Paul, S.; Goutam, K.; Kundu, C.N.
Source: Self-asserted source
Dr. Somya Ranjan Dash via Scopus - Elsevier

Combination of talazoparib and olaparib enhanced the curcumin-mediated apoptosis in oral cancer cells by PARP-1 trapping

Journal of Cancer Research and Clinical Oncology
2022-12 | Journal article
Part of ISSN: 0171-5216
Part of ISSN: 1432-1335
Contributors: Subhajit Chatterjee; Ajit Kumar Dhal; Subarno Paul; Saptarshi Sinha; Biswajit Das; Somya Ranjan Dash; Chanakya Kundu
Source: Self-asserted source
Dr. Somya Ranjan Dash
grade
Preferred source (of 2)‎

Resveratrol Nanoparticle attenuates metastasis and angiogenesis by deregulating inflammatory cytokines through inhibition of CAFs in oral cancer by CXCL-12/IL-6 dependent pathway

The Journal of Nutritional Biochemistry
2022-12 | Journal article
Part of ISSN: 0955-2863
Contributors: Rajalaxmi Pradhan; Subarno Paul; Biswajit Das; Saptarshi Sinha; Somya Ranjan Dash; Mahitosh Mandal; Chanakya Kundu
Source: Self-asserted source
Dr. Somya Ranjan Dash
grade
Preferred source (of 2)‎

Olaparib enhances the Resveratrol-mediated apoptosis in breast cancer cells by inhibiting the homologous recombination repair pathway

Experimental Cell Research
2022-11 | Journal article
Part of ISSN: 0014-4827
Contributors: Saptarshi Sinha; Subhajit Chatterjee; Subarno Paul; Biswajit Das; Somya Ranjan Dash; Chinmay Das; Chanakya Kundu
Source: Self-asserted source
Dr. Somya Ranjan Dash
grade
Preferred source (of 2)‎

NIR irradiation enhances the apoptotic potentiality of quinacrine-gold hybrid nanoparticles by modulation of HSP-70 in oral cancer stem cells

Nanomedicine: Nanotechnology, Biology and Medicine
2022-02 | Journal article
Part of ISSN: 1549-9634
Source: Self-asserted source
Dr. Somya Ranjan Dash
grade
Preferred source (of 2)‎

Photothermal Therapy: A New Approach to Eradicate Cancer

Current Nanoscience
2022-01 | Journal article
Part of ISSN: 1573-4137
Source: Self-asserted source
Dr. Somya Ranjan Dash
grade
Preferred source (of 2)‎

Surface functionalized gold nanorods for plasmonic photothermal therapy

Materials Today: Proceedings
2021 | Journal article
Part of ISSN: 2214-7853
Source: Self-asserted source
Dr. Somya Ranjan Dash
grade
Preferred source (of 2)‎

Nectin-4 promotes lymphangiogenesis and lymphatic metastasis in breast cancer by regulating CXCR4-LYVE-1 axis

Vascular Pharmacology
2021-10 | Journal article
Part of ISSN: 1537-1891
Source: Self-asserted source
Dr. Somya Ranjan Dash
grade
Preferred source (of 2)‎

Quinacrine Based Gold Hybrid Nanoparticles Caused Apoptosis through Modulating Replication Fork in Oral Cancer Stem Cells

Molecular Pharmaceutics
2020-07-06 | Journal article
Part of ISSN: 1543-8384
Part of ISSN: 1543-8392
Source: Self-asserted source
Dr. Somya Ranjan Dash
grade
Preferred source (of 2)‎

Promising opportunities and potential risk of nanoparticle on the society

IET Nanobiotechnology
2020-06 | Journal article
Part of ISSN: 1751-8741
Part of ISSN: 1751-875X
Source: Self-asserted source
Dr. Somya Ranjan Dash
grade
Preferred source (of 2)‎

Peer review (7 reviews for 2 publications/grants)

Review activity for Cancer Biology & Medicine. (1)
Review activity for Journal of ethnopharmacology. (6)